Dual antibody stimulation: role of monocyte products and activation requirements of T cell subsets.
Using the model of dual antibody stimulation (cross-linking anti-CD3 BMA030-F(ab')2 antibodies with subset specific anti-T cell antibodies, i.e., anti-CD4 or anti-CD8 antibodies) we investigated the role of monocyte products in eliciting IL2 production and asked whether T cell subsets differ in their activation requirements. We found that activation mechanisms of dual antibody stimulation were equal for CD4 and CD8 as well as CD4 CDw29 and CD4 CD45R T cell subsets: dual antibody stimulation was necessary to induce responsiveness to soluble monocyte products which trigger IL2 synthesis. IL2 production induced by soluble monocyte products was measured in CD4 and CD8 T cells as specific IL2 mRNA expression and with a biological assay. Combined actions of IL1 beta and TNF alpha were identified as active monocyte products as (a) treatment of LPS-stimulated monocyte supernatants with anti-IL1 beta and anti-TNF alpha antibodies abrogated the proliferation inducing effect of monocyte supernatants and (b) addition of rIL1 beta and/or rTNF alpha enhanced proliferation of T cells stimulated by dual antibody cross-linking. If both recombinant monokines were added simultaneously a potentiated proliferative effect was observed. Whereas rIL1 beta plus/or rTNF alpha sustained proliferation, only rIL1 beta but not rTNF alpha induced IL2 synthesis in T cell subsets stimulated by dual antibody cross-linking.
Institute for Clinical Immunology, Inselspital, CH 3010 Bern, Switzerland.
F
F
Bettens
C
C
Walker
F E
FE
Maly
W J
WJ
Pichler
D015703:Antigens, CD / Q000276:immunology*; D000943:Antigens, Differentiation / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D016827:CD8 Antigens; D002478:Cells, Cultured; D006801:Humans; D007156:Immunologic Memory; D066298:In Vitro Techniques; D019012:Integrin beta1; D007375:Interleukin-1 / Q000502:physiology; D007376:Interleukin-2 / Q000096:biosynthesis / Q000494:pharmacology; D017493:Leukocyte Common Antigens; D008213:Lymphocyte Activation; D009000:Monocytes / Q000276:immunology*; D015846:Monokines / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000945:Antigens, Differentiation, T-Lymphocyte; D016827:CD8 Antigens; D019012:Integrin beta1; D007375:Interleukin-1; D007376:Interleukin-2; D015846:Monokines; D014409:Tumor Necrosis Factor-alpha; D017493:Leukocyte Common Antigens